resistant-vs-parental-fgsea-simplified.Rmd

syn69980396

Created By Sasha Scott Sasha.scott

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
initiative: Other
fundingAgency: Other

resistant-vs-parental-fgsea-simplified.Rmd page is loading…